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morbidity after sural nerve graft harvesting:
a survey in 41 patients
Alexander Hallgren, Anders Björkman, Anette Chemnitz and Lars B Dahlin*Abstract
Background: The sural nerve is the most commonly used nerve for grafting severe nerve defects. Our aim was to
evaluate subjective outcome in the lower leg after harvesting the sural nerve for grafting nerve defects.
Methods: Forty-six patients were asked to fill in a questionnaire to describe symptoms from leg or foot, where the
sural nerve has been harvested to reconstruct an injured major nerve trunk. The questionnaire, previously used in
patients going through a nerve biopsy, consists of questions about loss of sensation, pain, cold intolerance,
allodynia and present problems from the foot. The survey also contained questions (visual analogue scales; VAS)
about disability from the reconstructed nerve trunk.
Results: Forty-one out of 46 patients replied [35 males/6 females; age at reconstruction 23.0 years (10–72); median
(min-max), reconstruction done 12 (1.2-39) years ago]. In most patients [37/41 cases (90%)], the sural nerve graft
was used to reconstruct an injured nerve trunk in the upper extremity, mainly the median nerve [19/41 (46%)].
In 38/41 patients, loss of sensation, to a variable extent, in the skin area innervated by the sural nerve was noted.
These problems persisted at follow up, but 19/41 noted that this area of sensory deficit had decreased over time.
Few patients had pain and less than 1/3 had cold intolerance. Allodynia was present in half of the patients, but the
majority of them considered that they had no or only slight problems from their foot. None of the patients in the
study required painkillers. Eighty eight per cent would accept an additional sural nerve graft procedure if another
nerve reconstruction procedure is necessary in the future.
Conclusions: Harvesting of the sural nerve for reconstruction nerve injuries results in mild residual symptoms
similar to those seen after a nerve biopsy; although nerve biopsy patients are less prone to undergo an additional
biopsy.
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The sural nerve is located on the back of the lower leg. It
is formed by joining the medial sural cutaneous nerve with
the peroneal branch of the lateral sural cutaneous nerve
where after it runs down along the leg. It pierces the fascia
in the middle of the leg and is located superficially in the
fat together with the lesser saphenous vein behind the lat-
eral malleolus. The nerve innervates the skin mainly
around the heel, but in some individuals it innervates also
the lateral side of the foot, including the little toe [1].* Correspondence: lars.dahlin@med.lu.se
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reproduction in any medium, provided the orThe sural nerve is used in many ways in today’s medicine;
it can be used in nerve biopsies to assist in diagnosing
polyneuropathies of unclear origin and to detect efficiency
of pharmacological substances to treat neuropathy [2,3]. It
is important that the indications for a sural nerve biopsy
are accurate [4] since pain and discomfort may develop fol-
lowing the biopsy. In addition, the sural nerve is the most
common autologous donor nerve, in nerve grafting, to re-
construct severe nerve defects in both adults and children.
Although the sural nerve is extensively used as a donor
nerve, a limited number of studies have investigated the se-
quelae following harvesting of the sural nerve [5-9],l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patients that have undergone a sural nerve biopsy.
To be able to inform patients about possible residual
symptoms and subjective outcomes when the sural nerve
is used as a nerve graft or for a biopsy, knowledge about
pain, sensory deficit, allodynia and other problems follow-
ing harvesting of the sural nerve have to be improved.
Based on such knowledge, patients can be offered more
accurate and detailed information about possible sequelae
following the procedure, which should be put into per-
spective of the expected result of the nerve reconstruction.
Therefore, it is of interest to analyse to which extent the
symptoms occur when the sural nerve is used as a nerve
graft and also to compare this to the symptoms that are
seen after a sural nerve biopsy. Thus, our aim was to
evaluate subjective outcome in the lower leg after
harvesting the sural nerve for nerve grafting.
Methods
Patient material
Patients, operated on with nerve reconstruction at our
department between 1973 and 2010 with one or two
sural nerves (harvest of the whole length of the sural
nerve at reconstruction) used as nerve grafts, were iden-
tified by the hospital´s patient registration system. Ex-
clusion criteria were reconstruction of the sciatic or
tibial nerves on the same side as the sural nerve graft
was harvested and follow up less than 14 months.
Forty-six patients filled the criteria and were asked to
fill out a questionnaire [4,10] to describe symptoms
from the leg or the foot where the nerve graft was
harvested. The different parameters investigated in-
cluded gender, age at reconstruction, age at follow up,
time since injury, type of injured nerve, cause of injury,
type of incision on leg and the patient´s occupation.
The Central Ethical Review Board in Lund (i.e. regional
ethics committee) judged the study and found it sound.
A formal approval was not necessary, since such a study
is not included in the applicable law (Research in
humans; law 2003:460). Thus, there were no ethical
problem involved (2011/607). Therefore, no formal in-
formed consent was needed from each patient, which
was not considered to affect the results.
Questionnaire
In the autumn of 2011 a questionnaire, used previously,
but slightly modified to better fit the present patients, to
evaluate residual subjective symptoms following sural
nerve biopsies in subjects with or without diabetes [4,10],
were sent to the 46 identified patients (Additional file 1).
It consists of 14 different questions where the patients
have to subjectively evaluate their post-operative symp-
toms from the lower leg. It includes loss of sensation, pain
in the operated area (and if so if the patient had to takepainkillers to cope with the pain), cold intolerance, numb-
ness and tingling sensation.
A scoring system, based on the patient´s subjective per-
ceptions and symptoms from the questionnaire, was cre-
ated to compare any symptoms and discomfort with the
overall general outcome of the reconstructed nerve. The
scoring system was designed as:
I.) Do you have loss of sensation in the operated foot
compared to the other foot? [no = 0; yes = 1].
II.) Do you feel pain in the foot/lower leg? [no = 0; day
time = 1; night time = 2].
III.) Do you have problem with cold intolerance in the
operated foot/lower leg? [no = 0; rarely = 1;
sometimes = 2; frequently = 3].
IV.)Have you experienced problems with increased
skin sensation when the skin is touched? [no = 0;
rarely = 1; sometimes = 2; frequently = 3].
V.) Do you experience discomfort or tingling along the
outside of the foot? [no = 0, impacts against surgical
site = 1; during walking = 2; at rest = 3].
VI.)How would you describe your problems at the
moment? [none = 0; mild = 1; affecting daily living =
2; severe = 3; disturbed sleep = 4].
The survey also contained three different visual analogue
scales (VAS) focusing on the outcome on the patients by
the injured and reconstructed nerve. The patients were
asked to rate a) at present how much does your nerve in-
jury, i.e. the reconstructed nerve, affect you? b) what impact
has your nerve injury had on leisure activities and c) how
does your injury affect your work or school attendance?
For comparison, the results from a previous study, using
the same questionnaire, describing the postoperative com-
plaints after a whole, not a fascicular, sural nerve biopsy
had been taken in 21 subjects without diabetes [4].
Statistics
Values are presented as median (min – max) or numbers
(%). Mann Whitney U-test was used to test for any signifi-
cant difference between patients with an age ≤ or > 20 years
of age at injury and Kruskal-Wallis to detect any differ-
ences between the various injuries leading up to the nerve
grafting procedures. Correlations were done with the
Spearman correlation test. A p-value of < 0.05 was ac-
cepted as significant. Analyses were done with using
StatView for windows (SAS Institute Inc, Cary, NC, USA,
version 5.0.1) and IBM SPSS Statistics (Statistical Package
for the Social Sciences, SPSS Inc., Chicago, Il, USA) ver-
sion 20 for Mac.
Results
Patients’ characteristics are shown in Table 1. Forty-one
out of 46 patients responded to the questionnaire
Table 1 Patient characteristics
Gender [male/female]: 35/6 (85/15%)




Reconstructed nerve: Nerves in lower extremity 4/41 patients
Nerves in upper extremity 40/41 patients
Brachial plexus 3/41 patients
Occupation: Student 9/41 (22%)
Non-manual labour 4/41 (10%)
Manual labour 15/41 (37%)
Retired 1/41 (2%)
Unknown 12/41 (29%)
Values are numbers (%) or median (min-max).
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23 years (min-max 10–72)]. The nerve reconstructions
were done at a median of 12 years (min-max 1.2-
39 years) ago. In 22/41 (54%) of the patients multiple in-
cisions were used and in 6/41 (15%) of the cases a single
longitudinal incision was the surgical technique of
choice when harvesting the sural nerve. In 13/41 (32%)
of the cases the surgical notes did not say which type of
incision the surgeon used. There were no reports of
postoperative complications, such as infection or deep
vein thrombosis, in any of the patients included in this
study, where the whole length of the sural nerve was
harvested.
Residual symptoms from the foot and leg
The residual symptoms following harvesting of the sural
nerve did not depend on type of injury for which the
nerve was harvested (p = 0.58). In most patients [37/41
cases (90%)], the sural nerve graft was used to recon-
struct one or several nerve trunks in the upper extrem-
ity; mainly the median nerve [(19/41 (46%); Table 1].
Discomfort from the leg was noted in 26/41 (63%) of the
patients directly following surgery (Table 2). 38/41 (93%)
had loss of sensation, to a variable extent, in the skin
areas innervated by the sural nerve, which persisted at
follow up. However, 19/41 (46%) patients noted that this
area had decreased over time. Immediately following the
operation, 18/41 (44%) experienced pain in the foot,
while 21 (51%) did not (no reply from two patients). The
pain did not, however, presently require more potent
painkillers in any of the cases. Instead, it was consist-
ently graded as mild by the patients and only 3/41 (5%)
had pain during night-time.
The patients were asked to mark the area of the skin
with sensory loss after harvesting (question number five).
The image (i.e. a topographic map) displayed in Figure 1
shows a combined illustration of all the patients’ drawings.The more intense red colour of certain areas, the more pa-
tients have experienced symptoms from this area. The re-
sults indicate that 93% of the patients noticed impaired
sensation around the heel. In 5/41 (12%) cases, there were
no drawings at all in the survey.
Less than one third of the patients had symptoms, such
as cold intolerance, and of those that had; only three clas-
sified them as frequent. Instead, the most common grade
was “sometimes” [6/41 (15%); Table 2]. Allodynia was
present in half of the patients 21/41 (51%), and of those af-
fected the most common occasion was “rare” [9/21
(43%)]. A similar number of patients [i.e. 22/41 (54%)] ex-
perienced discomfort or tingling sensations along the lat-
eral side of the foot. However, they only perceived such
symptoms when the area of previous incision was
percussed [15/41 (37%)]; few patients [6/41 (15%)] had tin-
gling sensations in the foot at rest.
On the question on how the symptoms from the sural
nerve harvest affected the patients at the moment, 2/41
(5%) classified it as powerful; 5/41 (12%) felt that it af-
fected their daily activities; and the majority 35/41 (85%)
responded that it was mild or none at all. No patients
had sleeping problems due to symptoms. If necessary in
the future 36/41 (88%) patients were positive to another
sural nerve graft procedure.
Disability of the reconstructed nerve injury and its impact
on leisure, school and work activities
The patients considered the overall disability (VAS 0–100)
from their reconstructed nerve injury as low [25 (0–100)],
with little impact on their leisure activity, school or work
activities [8.5 (0–100) and 11.5 (0–100), respectively].
Residual symptoms and correlation with general outcome
of nerve reconstruction and age
The results of the scoring system of residual symptoms in
the leg showed a low value [3.5 (0–13)]. The residual symp-
tom score did correlate with the VAS score of the general
outcome (rho-value = 0.45; p = 0.004), but did not correlate
with the time of follow up (p = 0.39). Age at injury did not
correlate with general outcome or residual symptoms
scores (p > 0.05). In addition, there were no differences in
residual symptoms (p = 0.86) or general outcome of recon-
struction of the nerve injury (p = 0.43) between subjects
that had their injured nerve reconstructed with a sural
nerve graft at an age ≤ or > 20 years of age.
Discussion
The present study shows that symptoms in the lower leg
after harvesting the sural nerve for reconstructive sur-
gery are relatively modest and include sensory loss, tin-
gling sensations and sensitive to cold. More than half of
the patients did not experience any discomfort immedi-




Healthy patients with sural nerve biopsy
(Dahlin et al. 1997) [4]: (n=21)
1. Did you have any discomfort in the foot directly after the operation?
Yes 15 (37%) 2 (10%)
No 24 (59%) 19 (90%)
No reply 2 (5%)
2. Did you experience any loss of sensation in the
operated area after the operation?
Yes 38 (93%) 19 (90%)
No 3 (7%) 2 (10%)
3. Did you experience pain in the operated area after the operation?
Yes 21 (51%) 7 (33%)
No 18 (44%) 14 (67%)
No reply 2 (5%)
4. Do you have loss of sensation in the operated foot
compared with the other foot?
Yes 35 (85%) 19 (90%)
No 6 (15%) 2 (10%)
5. Mark the area of sensory deficit in the figure.
See Figure 1 for details.
5 (12%) did not draw at all.
6. (a) Has the area with loss of sensation decreased
compared with the time directly following surgery?
Yes 19 (46%) 8 (38%)
No 22 (54%) 13 (62%)
(b) If yes, how much (%)
0-25 3 (7%) 2 (10%)
26-50 6 (15%) 1 (5%)
51-75 7 (17%) 3 (14%)
76-100 3 (7%) 2 (10%)
7. (a) Do you feel pain in the foot/lower leg?
Yes 8 (20%) 1 (5%)
No 33 (80%) 20 (95%)
(b) When?
Day time 5 (12%) 0 (0%)
Night time 2 (5%) 0 (0%)
Day time and Night time 1 (2%) 1 (5%)
8. (a) Do you have problems with cold intolerance
in the operated foot/lower leg?
Yes 12 (29%) 1 (5%)
No 29 (71%) 20 (95%)
(b) If yes, how often?
Frequently 3 (7%) 0 (0%)
Sometimes 6 (15%) 0 (0%)
Rarely 3 (7%) 1 (5%)
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Table 2 Questionnaire (Continued)
9. (a) Have you experienced problems with increased
skin sensation when the skin is touched?
Yes 21 (51%) 7 (33%)
No 20 (49%) 14 (67%)
(b) If yes, how often?
Frequently 7 (17%) 0 (0%)
Sometimes 5 (12%) 4 (19%)
Rarely 9 (22%) 3 (14%)
10.(a) Do you experience discomfort or tingling along the
outside of the foot?
Yes 22 (54%) 10 (48%)
No 19 (46%) 11 (52%)
(b) If so, when do these symptoms occur?
At rest 6 (15%) 3 (14%)
During walking 4 (10%) 1 (5%)
Impact against surgical site 15 (37%) 6 (29%)
11. How would you describe your problems at the moment?
Disturbed sleep 0 (0%) 0 (0%)
Powerful 2 (5%) 1 (5%)
Affecting daily living 5 (12%) 1 (5%)
Mild 19 (46%) 11 (52%)
None 16 (39%) 8 (38%)
12. Do you have to take painkillers often?
Yes 0 (0%) 0 (0%)
No 37 (100%) 21 (100%)
13. (a) Do you have any disease that can affect the nervous system,
for example; diabetes, vitamin deficiency or thyroid disease.
Yes 3 (7%) -
No 38 (93%) -
(b) If yes, which?
Diabetes mellitus -
Thyreoiditis
14. A theoretical question: would you be positive to have your other sural nerve
harvested if you had to undergo another nerve reconstructive surgery?
Yes 36 (88%) 7 (33%)
No 5 (12%) 14 (67%)
Right now how much does your nerve injury affect you? (VAS) 25 (0–100) -
[0 = no impact at all; 100 = severe impact]
What impact has your nerve injury had on leisure activities? (VAS) 8.5 (0–100) -
[0 = no impact at all; 100 = severe impact]
How does your injury affect your work or school attendance? (VAS) 11.5 (0–100) -
[0 = no impact at all; 100 = severe impact]
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the sural nerve. With this in mind, the nerve harvest pro-
cedure can be considered a safe procedure in healthy indi-
viduals. The results correlate well with previously publishedstudies [5-9,11], where it was concluded that the majority
of patients tolerate harvest of a sural nerve well and that
there are only minor persisting symptoms from the donor
site, which was irrespective of the length of follow up.
Figure 1 A combined illustration, i.e. a topographic map, of all the
patients’ drawings of the subjective sensory loss. The more intense
the red colour of certain areas was, the more patients have experienced
symptoms from this area. In 5/41 (12%) cases, there was no drawing.
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tients [7].
The subjectively most common symptom, as expected
[5] and experienced by over 90% of the present patients,
was some degree of sensory loss at the foot most com-
monly in the skin around the heel (Figure 1), which cor-
respond well with our previous results [4,7-10], where
the same questionnaire was used to evaluate sequele
after biopsy of the whole sural nerve. Interestingly, the
patients experienced that the area of sensory loss in the
skin decreased over time. In accordance, healthy subjects
also notice a similar phenomenon after a sural nerve bi-
opsy [4,9,10,12]. Previous studies, based on telephone
interviews, did not focus on reduction of the sensory loss
[6,11]. The gradual decrease of the area of sensory loss
may depend on a combination of collateral sprouting from
sensory nerves adjacent to the cutaneous area formerly in-
nervated by the sural nerve [9,12] and brain plasticity
[6,9,13]. Information, regarding the possibility for sensory
loss around the heel and lateral foot and that this area
may decrease over time as well as information about mild
or intermittent allodynia seen in 50% of the patients,
should be provided to the patients before harvesting the
sural nerve. The experienced pain, both immediately and
years after the sural nerve harvesting, was described
mostly as mild or none at all, which is consistent with our
previous study on symptoms following a sural nerve bi-
opsy in healthy volunteers [10]. Interestingly, there was no
need among our patients to presently use potent pain-
killers. In few patients (n = 3) the sural nerve was
harvested bilateral. Thereby, it was not possible to statisti-
cally test for any differences in subjective outcome of the
harvest procedure or to ask them to compare with the
contralateral side. In addition, we anticipated that the pa-
tients operated on bilaterally responded on the subjectiveoutcome of the procedure as related to their possible
worse side. This is a limitation and in future use of this
questionnaire it should be clearly stated.
The overall score, how the patients experienced their
general outcome of the reconstructed nerve [median = 25;
highest score 100], were rather low (i.e. limited problems)
and with minor problems from the donor site [median = 3;
maximal score 16]; scores that correlated with each other,
i.e. a worse result of the reconstruction procedure correlated
positively with residual problems from the sural nerve har-
vest. Such a finding may be understandable, but one should
also consider psychological mechanisms in this context;
thus, a poor result may lead to that the patient experience
more problems from the leg. A number of patients (37%)
had demanding physical job, such as factory worker or auto
mechanic, but the impact of the nerve injury on their work
capability was surprisingly low. Two patients were unable
to return to their regular work. Their work tasks included
lifting of heavy objects and requirements to work manually
with equal use of both arms and hands. However, the main
reason that they had to change occupation was the severe
nerve injury in their upper extremities requiring nerve
grafting. Miloro et al. [5] described an association between
an age >38 years and a worst general outcome locally in the
leg after harvesting the sural nerve, but we did not see any
difference in residual symptom or general outcome score in
the patients with an age ≤ or > 20 years of age (i.e. injury
during childhood and adolescence) at the time of recon-
struction. In addition, age did not correlate with residual
symptoms or general outcome score. Thus, such informa-
tion should be provided to the patients that undergo a
nerve reconstruction procedure. Harvest of the sural nerve
for nerve reconstruction is a safe procedure also in paediat-
ric patients [7]. Recently, it was reported that outcome of
nerve repair in the forearm is worse when such a nerve
injury is repaired or reconstructed after the age of 12 years
[14]. Notably, most of the present patients were above
12 years of age, which may influence the results.
There are also other limitations of the study since some
patients were operated on 30 years ago [8]. They may have
difficulties to remember the immediate postoperative
symptoms. Interestingly, the length of follow up did not
correlate with the residual symptoms (i.e. value of total
score). Another limitation is that the patients included
had various nerve injuries, extending from a pure nerve
injury to a complete amputation of their forearm or even
a brachial plexus injury. Such factors may influence how
the patients experience their illness and thus their answers
in the questionnaire. However, according to the response,
the experience of residual symptoms in the foot or leg
after harvesting the sural nerve is not dependent on type
of nerve injury. Notably, here we used a questionnaire sent
to the patients allowing them to unbiased fill out the ques-
tions. A previous study [6] has been based on answers
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that the subjects may be influenced by the person
interviewing them.
As always, it is a matter of balancing benefits and risks
against each other in nerve reconstruction procedures. In
the case of a new nerve injury, 36 out of 41 patients would
accept an additional sural nerve grafting procedure if ne-
cessary. The positive attitude to further surgery can be
explained by that the majority of the patients´ injuries in
their extremities affect their daily living much more than
the residual symptoms that arise after harvesting the sural
nerve. In contrast, a reduced willingness to perform an
additional sural biopsy from the contralateral side is low
among subjects with or without diabetes although they
may have similar symptoms after the biopsy [4,10]
(Table 2). Only 5% graded their symptoms as severe, but
none of the patients in any of the studies experienced
symptoms disturbing sleep [4,10]. Thus, patients, who had
a whole sural biopsy, were not nearly as willing to undergo
a further harvest of the sural nerve [7/21 (33%)] as the pa-
tients in the present study [36/41 (88%)], which is reason-
able since the present patients would have a greater gain
from their nerve graft reconstruction.
Conclusions
We conclude that harvest of a sural nerve to reconstruct
an injured nerve trunk is a safe procedure with mild re-
sidual symptoms similar to those seen after a sural nerve
biopsy, but such patients are less prone to undergo an
additional biopsy.
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